GWN Securities Inc. Makes New $278,000 Investment in Medpace Holdings, Inc. (NASDAQ:MEDP)

GWN Securities Inc. bought a new position in Medpace Holdings, Inc. (NASDAQ:MEDP) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 809 shares of the company’s stock, valued at approximately $278,000.

Other large investors have also recently added to or reduced their stakes in the company. R Squared Ltd acquired a new position in shares of Medpace during the fourth quarter valued at $30,000. SBI Securities Co. Ltd. acquired a new position in shares of Medpace during the fourth quarter valued at $31,000. Stone House Investment Management LLC acquired a new position in shares of Medpace during the third quarter valued at $33,000. Jones Financial Companies Lllp increased its holdings in shares of Medpace by 2,750.0% during the fourth quarter. Jones Financial Companies Lllp now owns 114 shares of the company’s stock valued at $38,000 after purchasing an additional 110 shares during the period. Finally, Lindbrook Capital LLC increased its holdings in shares of Medpace by 27.6% during the fourth quarter. Lindbrook Capital LLC now owns 134 shares of the company’s stock valued at $45,000 after purchasing an additional 29 shares during the period. 77.98% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Robert W. Baird raised their price target on Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a report on Monday, January 27th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $381.44.

Medpace Stock Up 0.4 %

NASDAQ:MEDP opened at $326.34 on Tuesday. The business’s 50-day moving average price is $339.97 and its 200 day moving average price is $340.56. The firm has a market cap of $9.94 billion, a P/E ratio of 25.84, a PEG ratio of 3.81 and a beta of 1.47. Medpace Holdings, Inc. has a 52-week low of $302.01 and a 52-week high of $459.77.

Medpace (NASDAQ:MEDP) last released its earnings results on Monday, February 10th. The company reported $3.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.96 by $0.71. Medpace had a return on equity of 51.48% and a net margin of 19.17%. Sell-side analysts expect that Medpace Holdings, Inc. will post 12.29 EPS for the current year.

About Medpace

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.